Cargando...
Blood-Brain Barrier and Delivery of Protein and Gene Therapeutics to Brain
Alzheimer’s disease (AD) and treatment of the brain in aging require the development of new biologic drugs, such as recombinant proteins or gene therapies. Biologics are large molecule therapeutics that do not cross the blood-brain barrier (BBB). BBB drug delivery is the limiting factor in the futur...
Gardado en:
| Publicado en: | Front Aging Neurosci |
|---|---|
| Autor Principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Frontiers Media S.A.
2020
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6966240/ https://ncbi.nlm.nih.gov/pubmed/31998120 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fnagi.2019.00373 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|